Press & Media

University "G. D'Annunzio" of Chieti Presents Data on PlexBio Technology at MDX Conference


PlexBio is pleased to recognize that Dr. Nicla Borrelli from the University "G. D'Annunzio", Chieti, Italy, will be presenting at 6th International Molecular Diagnostics Europe conference at Lisbon Portugal, from May 22-24, 2018 on results from studies using PlexBio’s IntelliPlex™ multiplexing technology. ...more

Euroclone Signs Distribution Agreements with PlexBio for the IntelliPlex™ Instrument System and Reagents


PlexBio Co., Ltd, an emerging multi-national diagnostic company, has signed an agreement with Euroclone S.p.A. of Milan to be the exclusive distributor its IntelliPlex™ 1000 πCode Processor and PlexBio™ 100 Fluorescent Analyzer for use in the Italian life science research market. ...more

PlexBio Presents Multiplex Mutation Analysis for Cancer Management by πCode Technology at Molecular Med Tri-Con 2018


San Francisco, CA (February 14, 2018) – PlexBio Co., Ltd. presented scientific data on the development and use of a series of novel multiplex assays on the company’s IntelliplexTM instrument system at this week’s 25th Molecular Med Tri-Conference in San Francisco, CA. ...more

PlexBio Expands Collaboration with Denka to Co-Develop an Infectious Disease Diagnostic System


Taipei, Taiwan – January 25, 2018 – PlexBio Co., Ltd. announced today that it plans to expand its collaboration agreement with Denka Co., Ltd. to include a new program to co-develop a molecular diagnostic system for Infectious Disease ...more

PlexBio Ranks Among Top Growing Companies in Asia Pacific


Taipei, Taiwan – January 5, 2018 - PlexBio Co., Ltd. has been recognized as being among the fastest growing technology companies in the Asia Pacific region according to the Deloitte Technology Fast 500TM awards program for 2017. ...more

< 1 | 2 | 3 | >